OnCo
Learn & contribute

Review queue

0 of 3,377 reviewable pages carry a named review. The queue below ranks the rest by reach, stakes and staleness, so a reviewer with an hour knows where it counts most. Signing off is an issue form; a maintainer verifies identity and records the review.

Coverage

Pages reviewed
0 of 3,377 (0%)
Expert sign-offs
0
clinical, scientific and regulatory tracks
Patient-advocate sign-offs
0
TL;DRs, simple text and questions
KindPagesExpertAdvocateAny reviewTracks needed
Cancer64000 (0%)Expert (clinical), Patient advocate
Front19000 (0%)Patient advocate
Technology348000 (0%)Expert (scientific)
Target92000 (0%)Expert (scientific)
Product377000 (0%)Expert (regulatory), Expert (clinical), Patient advocate
Pathway80000 (0%)Expert (scientific)
Term600000 (0%)Patient advocate
Trial401000 (0%)Expert (clinical)
Pairing85000 (0%)Expert (scientific)
Roadmap13000 (0%)Expert (scientific)
Idea1,107000 (0%)Expert (scientific)
Bottleneck45000 (0%)Expert (scientific)
Key paper146000 (0%)Expert (scientific)

Companies, institutions, people, collections and journals are attributed (who wrote the record) rather than reviewed; organisations correct their own records through Suggest an edit.

The queue

Score out of 100: reach (graph connections, log-scaled, up to 40), stakes (evidence score or a kind default, up to 30), staleness (days since the record's asOf, a year is 30). Pages already reviewed on every track they need within a year sort to the bottom. Formula in src/lib/review-queue.ts.

#PageScoreLinksEvidenceAgeNeeds
1
CancerAcute lymphoblastic leukaemia
70274n/a6 dExpert (clinical), Patient advocateReview this page
2
CancerAcute myeloid leukaemia
70308n/a6 dExpert (clinical), Patient advocateReview this page
3
CancerAdrenocortical carcinoma
7051n/a2 dExpert (clinical), Patient advocateReview this page
4
CancerAnal cancer (squamous cell carcinoma)
7052n/a2 dExpert (clinical), Patient advocateReview this page
5
TechnologyAnti-angiogenic therapy
7054996 dExpert (scientific)Review this page
6
CancerBasal cell carcinoma
7031n/a2 dExpert (clinical), Patient advocateReview this page
7
CancerBiliary tract cancer (cholangiocarcinoma)
70175n/a6 dExpert (clinical), Patient advocateReview this page
8
CancerBladder & urothelial cancer
70265n/a3 dExpert (clinical), Patient advocateReview this page
9
CancerCancer of unknown primary (CUP)
7041n/a2 dExpert (clinical), Patient advocateReview this page
10
CancerCervical cancer
70282n/a3 dExpert (clinical), Patient advocateReview this page
11
CancerChronic lymphocytic leukaemia
70226n/a6 dExpert (clinical), Patient advocateReview this page
12
CancerChronic myeloid leukaemia (CML)
7058n/a2 dExpert (clinical), Patient advocateReview this page
13
CancerColorectal cancer
70604n/a3 dExpert (clinical), Patient advocateReview this page
14
CancerCutaneous squamous cell carcinoma
7047n/a2 dExpert (clinical), Patient advocateReview this page
15
CancerDiffuse large B-cell lymphoma
70314n/a3 dExpert (clinical), Patient advocateReview this page
16
CancerEndometrial cancer
70192n/a3 dExpert (clinical), Patient advocateReview this page
17
CancerEwing sarcoma
7067n/a2 dExpert (clinical), Patient advocateReview this page
18
CancerFollicular lymphoma
7079n/a2 dExpert (clinical), Patient advocateReview this page
19
CancerGastric & gastro-oesophageal junction cancer
70334n/a3 dExpert (clinical), Patient advocateReview this page
20
CancerGastrointestinal stromal tumour (GIST)
7049n/a2 dExpert (clinical), Patient advocateReview this page
21
CancerGestational trophoblastic neoplasia
7043n/a2 dExpert (clinical), Patient advocateReview this page
22
CancerGlioma & glioblastoma
70263n/a4 dExpert (clinical), Patient advocateReview this page
23
CancerHairy cell leukaemia
7041n/a2 dExpert (clinical), Patient advocateReview this page
24
CancerHead and neck squamous cell carcinoma
70317n/a6 dExpert (clinical), Patient advocateReview this page
25
CancerHepatoblastoma
7034n/a2 dExpert (clinical), Patient advocateReview this page
26
CancerHepatocellular carcinoma
70291n/a6 dExpert (clinical), Patient advocateReview this page
27
CancerHER2-positive breast cancer
70296n/a3 dExpert (clinical), Patient advocateReview this page
28
CancerHodgkin lymphoma
70175n/a3 dExpert (clinical), Patient advocateReview this page
29
CancerHR-positive / HER2-negative breast cancer
70619n/a3 dExpert (clinical), Patient advocateReview this page
30
TechnologyImmune checkpoint inhibitors
70317996 dExpert (scientific)Review this page
31
CancerKaposi sarcoma
7048n/a2 dExpert (clinical), Patient advocateReview this page
32
CancerMantle cell lymphoma
7071n/a2 dExpert (clinical), Patient advocateReview this page
33
CancerMedulloblastoma
7063n/a2 dExpert (clinical), Patient advocateReview this page
34
CancerMelanoma
70422n/a6 dExpert (clinical), Patient advocateReview this page
35
CancerMerkel cell carcinoma
7046n/a2 dExpert (clinical), Patient advocateReview this page
36
CancerMesothelioma
70137n/a3 dExpert (clinical), Patient advocateReview this page
37
TechnologyMonoclonal antibodies
70101996 dExpert (scientific)Review this page
38
CancerMultiple myeloma
70285n/a3 dExpert (clinical), Patient advocateReview this page
39
CancerMyelodysplastic syndromes / neoplasms (MDS)
7065n/a2 dExpert (clinical), Patient advocateReview this page
40
CancerMyeloproliferative neoplasms (PV, ET, myelofibrosis)
7060n/a2 dExpert (clinical), Patient advocateReview this page
41
CancerNasopharyngeal carcinoma
7054n/a2 dExpert (clinical), Patient advocateReview this page
42
CancerNeuroblastoma (paediatric)
70169n/a3 dExpert (clinical), Patient advocateReview this page
43
CancerNeuroendocrine tumours
70196n/a6 dExpert (clinical), Patient advocateReview this page
44
CancerNon-small-cell lung cancer
70714n/a4 dExpert (clinical), Patient advocateReview this page
45
CancerOesophageal cancer
70242n/a3 dExpert (clinical), Patient advocateReview this page
46
CancerOsteosarcoma
7070n/a2 dExpert (clinical), Patient advocateReview this page
47
CancerOvarian cancer
70320n/a3 dExpert (clinical), Patient advocateReview this page
48
CancerPancreatic ductal adenocarcinoma
70379n/a4 dExpert (clinical), Patient advocateReview this page
49
CancerPeripheral T-cell lymphomas (including cutaneous T-cell lymphoma)
7065n/a2 dExpert (clinical), Patient advocateReview this page
50
CancerPrimary CNS lymphoma
7047n/a2 dExpert (clinical), Patient advocateReview this page

Showing the top 50 of 3,377 reviewable pages.

By track

The ten highest-need pages for each track, so a clinician, a scientist, a regulatory specialist or an advocate can start without reading the whole queue.

Expert (clinical)

Standard-of-care rows against current NCCN and ESMO guidance; trial figures against the primary publication.

  1. Acute lymphoblastic leukaemiareview
  2. Acute myeloid leukaemiareview
  3. Adrenocortical carcinomareview
  4. Anal cancer (squamous cell carcinoma)review
  5. Basal cell carcinomareview
  6. Biliary tract cancer (cholangiocarcinoma)review
  7. Bladder & urothelial cancerreview
  8. Cancer of unknown primary (CUP)review
  9. Cervical cancerreview
  10. Chronic lymphocytic leukaemiareview
Expert (scientific)

Mechanism, biology and evidence tier accurately stated; nothing speculative presented as settled.

  1. Anti-angiogenic therapyreview
  2. Immune checkpoint inhibitorsreview
  3. Monoclonal antibodiesreview
  4. Androgen deprivation & AR pathway inhibitorsreview
  5. Antibody-drug conjugate (ADC)review
  6. Small-molecule kinase inhibitorsreview
  7. Topoisomerase-I inhibitors (and ADC payloads)review
  8. Cytotoxic chemotherapyreview
  9. Endocrine therapy (SERMs, AIs, SERDs)review
  10. Epigenetic drugs (HDAC, DNMT, EZH2, IDH, menin, BET)review
Expert (regulatory)

Approval dates, regions and indications match the label or agency notice.

  1. Bevacizumabreview
  2. Cabozantinibreview
  3. Everolimusreview
  4. Lenvatinibreview
  5. Pembrolizumabreview
  6. Trastuzumab deruxtecanreview
  7. Sunitinibreview
  8. Abiraterone acetatereview
  9. Azacitidinereview
  10. Daratumumabreview
Patient advocate

TL;DR, simple text and questions clear, non-alarming and accurate at the stated reading level.

  1. Acute lymphoblastic leukaemiareview
  2. Acute myeloid leukaemiareview
  3. Adrenocortical carcinomareview
  4. Anal cancer (squamous cell carcinoma)review
  5. Basal cell carcinomareview
  6. Biliary tract cancer (cholangiocarcinoma)review
  7. Bladder & urothelial cancerreview
  8. Cancer of unknown primary (CUP)review
  9. Cervical cancerreview
  10. Chronic lymphocytic leukaemiareview

Translations

Every translated TL;DR is machine-assisted until a named speaker of the language reviews it. Pages show MT until then and Reviewed after. Reviews are recorded in src/data/i18n/reviewed.ts.

LanguageTranslated TL;DRsReviewedReviewers
Spanish Español4480 (0%)0Review translations
Chinese 中文4480 (0%)0Review translations
Portuguese Português4480 (0%)0Review translations
Hindi हिन्दी4480 (0%)0Review translations

Spotted a wrong translation on one page? Use Translation fix; to sign off a batch, Translation review.

How to review

  1. Pick a page from the queue and read it with its linked sources open.
  2. Click Review this page. The issue form carries the checklist for your track: expert (clinical), expert (scientific), expert (regulatory), patient advocate. Say what you checked and what you found wrong, with sources.
  3. State your name, role and organisation, a profile URL we can verify, and your conflicts of interest for the last three years. “None declared” is a valid answer and is displayed.
  4. A maintainer verifies identity, fixes anything you flagged (each fix is a sourced edit through the same gate), then records the sign-off in src/data/reviews.ts. The badge appears on the page with your name, the date and your COI statement, and you appear on the roster.

A review is a statement about a page on a date, not an endorsement. Nothing is edited directly by reviewers or by anyone else: every change enters as an issue and is checked before it is merged. Tracks and verification rules: REVIEWERS.md.